CoChat

Protective Effects of PGC-1α Activators on Ischemic Stroke in a Rat Model of Photochemically Induced Thrombosis

Open access
Shakova, Fatima M., Kirova, Yuliya I., Silachev, Denis N., Romanova, Galina A., Morozov, Sergey G. · 2021 · Brain Sciences

The DOI matches its Crossref record; 103 of the 106 references it cites were found in a registry or an index; 21 of the 58 sources its claims cite were checked for support.

Abstract

The pharmacological induction and activation of peroxisome proliferator-activated receptor gamma coactivator 1 alpha (PGC-1α), a key regulator of ischemic brain tolerance, is a promising direction in neuroprotective therapy. Pharmacological agents with known abilities to modulate cerebral PGC-1α are scarce. This study focused on the potential PGC-1α-modulating activity of Mexidol (2-ethyl-6-methyl-3-hydroxypyridine succinate) and Semax (ACTH(4–7) analog) in a rat model of photochemical-induced thrombosis (PT) in the prefrontal cortex. Mexidol (100 mg/kg) was administered intraperitoneally, and Semax (25 μg/kg) was administered intranasally, for 7 days each. The expression of PGC-1α and PGC-1α-dependent protein markers of mitochondriogenesis, angiogenesis, and synaptogenesis was measured in the penumbra via immunoblotting at Days 1, 3, 7, and 21 after PT. The nuclear content of PGC-1α was measured immunohistochemically. The suppression of PGC-1α expression was observed in the penumbra from 24 h to 21 days following PT and reflected decreases in both the number of neurons and PGC-1α expression in individual neurons. Administration of Mexidol or Semax was associated with preservation of the neuron number and neuronal expression of PGC-1α, stimulation of the nuclear translocation of PGC-1α, and increased contents of protein markers for PGC-1α activation. This study opens new prospects for the pharmacological modulation of PGC-1α in the ischemic brain.

Overview

CoChat Summary

TL;DR

In a rat model of photochemically induced focal ischemic stroke, the authors found that Mexidol and Semax reduced brain injury and were associated with preservation and activation of PGC-1α in the penumbra. Mexidol generally showed stronger effects than Semax on infarct reduction, inflammatory-cell infiltration, and PGC-1α-related protein changes.

Key findings

  • In Stroke + Saline rats, the ischemic core covered 40% of the prefrontal cortex area at 1 day after PT, and the damage remained similar at 3 and 7 days; by 21 days there was a 25% retraction of the damage site with cyst formation.
  • A single dose given 2 h after PT reduced the necrotic area: 1.8-fold with Mexidol and 1.6-fold with Semax versus Stroke + Saline; after the 7-day course, the damaged region at 21 days was reduced by 3.5-fold (Mexidol) and 2.4-fold (Semax) versus Stroke + Saline.
  • In the penumbra, PT caused a 20% decrease in PGC-1α-immunopositive neurons at 24 h, while Mexidol and Semax maintained the total number of PGC-1α-expressing neurons at the control level and increased neurons with high/medium nuclear PGC-1α immunoreactivity; at 24 h, Mexidol raised high and medium nuclear PGC-1α by 40% and 30%, and Semax by 25% and 20% versus Stroke + Saline.
  • PGC-1α-dependent markers increased after ischemia and treatment, especially at 1 day: in Stroke + Saline, NRF1 increased by 200%, TFAM by 350%, NDUFV2 by 140%, SDHA by 200%, VEGF by 250%, and SYP by 130%; Mexidol also increased NRF1 by 40%, TFAM 100%, NDUFV2 30%, SDHA 100%, VEGF 80%, SYP 20%, and SUCNR1, while Semax increased NRF1 by 20%, TFAM 50%, NDUFV2 20%, SDHA 50%, and VEGF 40%.

Methods

  • Male Wistar rats (n = 96, 200–230 g, 8–9 weeks old) were assigned to four groups: Stroke + Saline, Stroke + Mexidol (100 mg/kg i/p), Stroke + Semax (25 μg/kg intranasal), and Control (n = 24 per group).
  • Focal ischemic stroke was modeled by photochemically induced thrombosis in the prefrontal cortex; animals were analyzed on Days 1, 3, 7, and 21 after stroke induction.
  • Outcomes included histology/morphometry of infarct core and penumbra, Western blotting for PGC-1α and related proteins, and immunohistochemistry for PGC-1α nuclear localization; group differences were tested with two-way ANOVA and Bonferroni post-hoc tests.

Limitations

  • Not stated in the paper.
  • Evident from the text: the study is an animal model in male rats, so direct clinical applicability to human stroke is not established in this paper.
  • Evident from the text: the experiments used a photochemically induced thrombosis model in the prefrontal cortex, which may not capture all features of human ischemic stroke.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.3390/brainsci11030325

Cites

103 of 103 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Figure 1 Mechanisms of positive regulation of PGC-1α by physiological/pharmacological modulators and basic PGC-1α-dependent molecular targets that determine neuroprotective effects. All arrows represent positive regulation (see explanations in text). Abbreviations: AICAR: 5-Aminoimidazole-4-carboxamide ribonucleotide; AMP: Adenosine monophosphate; AMPK: Adenosine monophosphate-activated protein kinase; BDNF: Brain-derived neurotrophic factor; CaMK: Ca2+/calmodulin-dependent protein kinase; cAMP: Cyclic adenosine monophosphate; CAT: Catalase; CREB: cAMP-responsive element-binding protein; ERRs: Estrogen-related receptors; GABARs: Gamma aminobutyric acid receptors; GHs: Glucocorticoid hormones; GPXs: Glutathione peroxidases; Mfn: Mitofusin; NAD: Nicotinamide adenine dinucleotide; NMDARs: N-methyl-D-aspartate receptors; NRF: Nuclear respiratory factor; PGC–1α: Peroxisome proliferator-activated receptor γ coactivator 1 α; PPARs: Peroxisome proliferator-activated receptors; SIRT: Silent information regulator two proteins (sirtuins); SOD: Superoxide dismutase; SP1: Specificity protein 1; SYP: Synaptophysin; TGF: Transforming growth factor; THs: Thyroid hormones; TRs: Thyroid hormone receptors; VEGF: Vascular endothelial growth factor.
Figure 1 Mechanisms of positive regulation of PGC-1α by physiological/pharmacological modulators and basic PGC-1α-dependent molecular targets that determine neuroprotective effects. All arrows represent positive regulation (see explanations in text). Abbreviations: AICAR: 5-Aminoimidazole-4-carboxamide ribonucleotide; AMP: Adenosine monophosphate; AMPK: Adenosine monophosphate-activated protein kinase; BDNF: Brain-derived neurotrophic factor; CaMK: Ca2+/calmodulin-dependent protein kinase; cAMP: Cyclic adenosine monophosphate; CAT: Catalase; CREB: cAMP-responsive element-binding protein; ERRs: Estrogen-related receptors; GABARs: Gamma aminobutyric acid receptors; GHs: Glucocorticoid hormones; GPXs: Glutathione peroxidases; Mfn: Mitofusin; NAD: Nicotinamide adenine dinucleotide; NMDARs: N-methyl-D-aspartate receptors; NRF: Nuclear respiratory factor; PGC–1α: Peroxisome proliferator-activated receptor γ coactivator 1 α; PPARs: Peroxisome proliferator-activated receptors; SIRT: Silent information regulator two proteins (sirtuins); SOD: Superoxide dismutase; SP1: Specificity protein 1; SYP: Synaptophysin; TGF: Transforming growth factor; THs: Thyroid hormones; TRs: Thyroid hormone receptors; VEGF: Vascular endothelial growth factor.CC BY · PubMed Central
Figure 2 (A) The scheme of modeling of the photothrombotic stroke. Photothrombosis of blood vessels is achieved via intravenous injection of Rose Bengal (40 mg/kg) and illumination with a white light (250 W halogen lamp) through a light fiber (inner diameter is 3 mm) of the skull over the prefrontal cortex. (B) Experimental timeframe. (C) Brain section stained with cresyl violet illustrating the bilateral sites of photothrombotic stroke induction. White and red arrows represent the lateral and central sites of penumbra, correspondingly, selected for the size/cell profile of ischemic penumbra analysis. Created with BioRender.com.
Figure 2 (A) The scheme of modeling of the photothrombotic stroke. Photothrombosis of blood vessels is achieved via intravenous injection of Rose Bengal (40 mg/kg) and illumination with a white light (250 W halogen lamp) through a light fiber (inner diameter is 3 mm) of the skull over the prefrontal cortex. (B) Experimental timeframe. (C) Brain section stained with cresyl violet illustrating the bilateral sites of photothrombotic stroke induction. White and red arrows represent the lateral and central sites of penumbra, correspondingly, selected for the size/cell profile of ischemic penumbra analysis. Created with BioRender.com.CC BY · PubMed Central
Figure 3 Dynamics of the development of ischemic damage of the prefrontal brain cortex in rats during the 7-day course of Mexidol or Semax treatment and 14 days after drug withdrawal. Photographs of rat prefrontal cortex slices were taken in the region with maximal cortex damage (at the level of 4.2 mm from the bregma) [62]. The slices were stained with hematoxylin and eosin (H&E). The border of the infarct area is marked with a dashed line. Under each image, the values of the sum of the damaged areas in both hemispheres are indicated, and the damaged area as a percentage of the prefrontal cortex is indicated in brackets. * p < 0.05 denotes a significant difference from the Stroke + Saline group at the appropriate time period; # p < 0.05 denotes a significant difference between the Stroke + Mexidol with Stroke + Semax groups at the appropriate time periods based on a two-way ANOVA with Bonferroni’s post-hoc multiple comparison test.
Figure 3 Dynamics of the development of ischemic damage of the prefrontal brain cortex in rats during the 7-day course of Mexidol or Semax treatment and 14 days after drug withdrawal. Photographs of rat prefrontal cortex slices were taken in the region with maximal cortex damage (at the level of 4.2 mm from the bregma) [62]. The slices were stained with hematoxylin and eosin (H&E). The border of the infarct area is marked with a dashed line. Under each image, the values of the sum of the damaged areas in both hemispheres are indicated, and the damaged area as a percentage of the prefrontal cortex is indicated in brackets. * p < 0.05 denotes a significant difference from the Stroke + Saline group at the appropriate time period; # p < 0.05 denotes a significant difference between the Stroke + Mexidol with Stroke + Semax groups at the appropriate time periods based on a two-way ANOVA with Bonferroni’s post-hoc multiple comparison test.CC BY · PubMed Central
Figure 4 Representative microphotographs of pathomorphological alterations in the penumbral area within 21 post-ischemic days and a 7-day course of Mexidol and Semax treatments. Frontal section through the infarction and penumbra. A fragment of the infarction (pale-stained area) is shown at the top of the photomicrographs. The slices were stained with H&E. Scale bar: 100 μm.
Figure 4 Representative microphotographs of pathomorphological alterations in the penumbral area within 21 post-ischemic days and a 7-day course of Mexidol and Semax treatments. Frontal section through the infarction and penumbra. A fragment of the infarction (pale-stained area) is shown at the top of the photomicrographs. The slices were stained with H&E. Scale bar: 100 μm.CC BY · PubMed Central
Figure 5 Effects of a 7-day Mexidol and Semax treatment course on the cellular composition of the penumbral zone at 1, 3, 7, and 21 days after PT. The diagram represents the quantitation of (A) the length of the penumbra, (B) neurons, (C) macrophages, and (D) neutrophils as the mean ± SEM. For Diagram A, the length (the distribution depth) of the central most extended site of the penumbra is represented by unhatched bars, while the lengths of the lateral sites are represented by the hatched bars. The experiments used six randomized microphotographs (images corresponding to the area of a penumbra of 0.1 mm2) of three slices from four rats. * p < 0.05 denotes a significant difference from the Control group; # p < 0.05 denotes a significant difference from the Stroke + Saline group in the same time period; Δ p < 0.05 denotes a significant difference from the previous observation time point based on a two-way ANOVA with Bonferroni’s post-hoc multiple comparison test.
Figure 5 Effects of a 7-day Mexidol and Semax treatment course on the cellular composition of the penumbral zone at 1, 3, 7, and 21 days after PT. The diagram represents the quantitation of (A) the length of the penumbra, (B) neurons, (C) macrophages, and (D) neutrophils as the mean ± SEM. For Diagram A, the length (the distribution depth) of the central most extended site of the penumbra is represented by unhatched bars, while the lengths of the lateral sites are represented by the hatched bars. The experiments used six randomized microphotographs (images corresponding to the area of a penumbra of 0.1 mm2) of three slices from four rats. * p < 0.05 denotes a significant difference from the Control group; # p < 0.05 denotes a significant difference from the Stroke + Saline group in the same time period; Δ p < 0.05 denotes a significant difference from the previous observation time point based on a two-way ANOVA with Bonferroni’s post-hoc multiple comparison test.CC BY · PubMed Central
Figure 6 Influence of a 7-day course of Mexidol and Semax treatment on PGC-1α expression and the levels of protein markers of PGC-1α activity in the penumbral zone for 21 days after ischemia. The diagrams represent the results of a densitometry analysis, expressed in percentages, of the corresponding protein bands on the Western blot images. Representative immunoblots of PGC-1α (A), NRF1 (B), TFAM (C), NDUFV2 (D), SDHA (E), cyt c1 (F), COX2 (G), ATP5A (H), SUCNR1 (I), VEGF (J), VE-cadherin (K), and Synaptophysin (L) target proteins are included in the figure. The number of animals used for Western blot densitometry was n = 3 per each experimental episode. * p < 0.01 denotes a significant difference from the Control group; # p < 0.01 denotes a significant difference from the Stroke + Saline group; statistical analysis: A two-way ANOVA with Bonferroni’s post-hoc multiple comparison test. I (Ischemia): Stroke + Saline group; I + M: Stroke + Mexidol group; I + S: Stroke + Semax group.
Figure 6 Influence of a 7-day course of Mexidol and Semax treatment on PGC-1α expression and the levels of protein markers of PGC-1α activity in the penumbral zone for 21 days after ischemia. The diagrams represent the results of a densitometry analysis, expressed in percentages, of the corresponding protein bands on the Western blot images. Representative immunoblots of PGC-1α (A), NRF1 (B), TFAM (C), NDUFV2 (D), SDHA (E), cyt c1 (F), COX2 (G), ATP5A (H), SUCNR1 (I), VEGF (J), VE-cadherin (K), and Synaptophysin (L) target proteins are included in the figure. The number of animals used for Western blot densitometry was n = 3 per each experimental episode. * p < 0.01 denotes a significant difference from the Control group; # p < 0.01 denotes a significant difference from the Stroke + Saline group; statistical analysis: A two-way ANOVA with Bonferroni’s post-hoc multiple comparison test. I (Ischemia): Stroke + Saline group; I + M: Stroke + Mexidol group; I + S: Stroke + Semax group.CC BY · PubMed Central
Figure 7 Effect of a 7-day treatment course of Mexidol and Semax on the expression and nuclear localization of PGC-1α in penumbral neurons at 1, 3, 7, and 21 days after PT of the prefrontal cortex. (A) Representative microphotographs of the immunohistochemical staining of rat prefrontal cortex slices. Bar: 50 μm. (B) Diagrams showing the number of PGC-1α-immunopositive neurons and neurons with high, middle, and low nuclear PGC-1α-immunoreactivity. The mean values of the number of cells were obtained by counting six randomized micrographs (images corresponded to the area of a penumbra 0.1 mm2) in three different sections from four rats for each experimental episode; data represent the mean ± SEM. * p < 0.05 denotes a significant difference from the Control group; # p < 0.05 denotes a significant difference from the Stroke + Saline group; Δ p < 0.05 denotes a significant difference from the first postoperative day (intra-group comparisons) based on a two-way ANOVA with Bonferroni’s post-hoc multiple comparison test. PGC-1α-IR: PGC-1α-immunoreactivity.
Figure 7 Effect of a 7-day treatment course of Mexidol and Semax on the expression and nuclear localization of PGC-1α in penumbral neurons at 1, 3, 7, and 21 days after PT of the prefrontal cortex. (A) Representative microphotographs of the immunohistochemical staining of rat prefrontal cortex slices. Bar: 50 μm. (B) Diagrams showing the number of PGC-1α-immunopositive neurons and neurons with high, middle, and low nuclear PGC-1α-immunoreactivity. The mean values of the number of cells were obtained by counting six randomized micrographs (images corresponded to the area of a penumbra 0.1 mm2) in three different sections from four rats for each experimental episode; data represent the mean ± SEM. * p < 0.05 denotes a significant difference from the Control group; # p < 0.05 denotes a significant difference from the Stroke + Saline group; Δ p < 0.05 denotes a significant difference from the first postoperative day (intra-group comparisons) based on a two-way ANOVA with Bonferroni’s post-hoc multiple comparison test. PGC-1α-IR: PGC-1α-immunoreactivity.CC BY · PubMed Central

Verification

Claims the paper makes

8 Valid · 5 Not valid · 11 Not checked · 89 Own results and interpretations

52 more claims

Create a free account to see all 113 claims and to verify the 5 references still open.

See all claims — free account
  • Probably not a substantial claim. 9
  • It may state two separate claims as one. 49

Create a free account to see these claims.

Citations

Cites

Show all 103 references

Research works printed but not linked: 3

  1. Paxinos, G., and Watson, C. (1998). The Rat Brain in Stereotaxic Coordinates, Academic Press. [4th ed.].
  2. Parker, G.A., and Picut, C.A. (2016). Atlas of Histology of the Juvenile Rats, Elsevier. [1st ed.].
  3. Hasegawa, A., and Furuhama, K. (1998). Atlas of the Hematology of the Laboratory Rat, Elsevier Science Ltd.. [1st ed.].

Cited by

See all 13

Metadata

Authors
Shakova, F. M., Kirova, Y. I., Silachev, D. N., Romanova, G. A., & Morozov, S. G.
Affiliations
  • Research Institute of General Pathology and Pathophysiology, the Russian Academy of Medical Sciences (RU)
  • Institute of General Pathology and Pathophysiology, Baltiyskaya Str. 8, 125315 Moscow, Russia
  • Peoples' Friendship University of Russia (RU)
Corresponding author
Shakova, Fatima M.
Venue
Brain Sciences
Publisher
MDPI AG
Published
2021-03-04
Volume
11
Issue
3
Pages
325
ISSN
2076-3425 (ISSN-L)
OpenAlex
W3134269086
Cited by
13
References
106
Citations by year
2026: 2 · 2025: 6 · 2023: 2 · 2022: 2 · 2021: 1
FWCI
0.52
Type
journal article
Language
en
Open access
Locations
  • Brain Sciences (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
This work was funded by the Institute of General Pathology and Pathophysiology (Federal Budget funding), was performed within the framework of the research &quot;Pathogenetic mechanisms of neurodegenerative diseases and the development of their complex therapy (0520-2019-0029)
Topics
  • Life Sciences › Neuroscience › Neurology › Neuroprotection in Cerebral Ischemia
  • Health Sciences › Medicine › Clinical Neurology › Acute Ischemic Stroke Management
  • Life Sciences › Neuroscience › Neurology › Neurological Disease Mechanisms and Treatments
Keywords
PGC-1α, ischemic stroke, photochemically induced thrombosis, Mexidol, Semax, neuroprotection, ischemic penumbra, mitochondrial biogenesis, angiogenesis, synaptogenesis, prefrontal cortex

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Protective Effects of PGC-1α Activators on Ischemic Stroke in a Rat Model of Photochemically Induced Thrombosis. https://app.cochat.ai/papers/10.3390/brainsci11030325
The paper
Shakova, F. M., Kirova, Y. I., Silachev, D. N., Romanova, G. A., & Morozov, S. G. (2021). Protective Effects of PGC-1α Activators on Ischemic Stroke in a Rat Model of Photochemically Induced Thrombosis. Brain Sciences. https://doi.org/10.3390/brainsci11030325

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.